[Echinococcosis complicated by paecilomycosis].
Two hundred and thirty-six echinococcosis patients aged 17 to 70 years were examined for paecilomycosis. Seventy-five subjects of different ages who were considered to be clinically healthy were prepared as a control. Of them who had physiological parameters of blood fungi, 24 subjects, including 9 subjects aged 17 to 23 years and 15 subjects aged 15 to 30 years, were eligible. The other examinees were patients with paecilomycosis of varying stages. Nizoral, fluconazole, diflucan, orungal, mycosyst, and teknazol, which have been tested by the authors, are proposed for use in paecilomycosis-complicated echinococcosis prior to and after surgery. It is advisable to use one fungicide. In this respect, the authors have conducted clinical trials that have yielded positive results.
Streliaeva
A V
AV
Sadykov
R V
RV
Lazareva
N B
NB
Samylina
I A
IA
Sadykov
V M
VM
Chebyshev
N V
NV
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D000935:Antifungal Agents / Q000627:therapeutic use; D002353:Carrier State / Q000175:diagnosis; D002986:Clinical Trials as Topic; D004443:Echinococcosis / Q000150:complications* / Q000175:diagnosis* / Q000601:surgery; D004446:Echinococcus / Q000145:classification / Q000302:isolation & purification; D006801:Humans; D008875:Middle Aged; D009181:Mycoses / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy; D010143:Paecilomyces / Q000145:classification* / Q000302:isolation & purification; D014610:Uzbekistan
D000935:Antifungal Agents